May 22, 2018 

Section 301 Committee 

U.S. International Trade Commission (USITC) 

500 E Street SW 

Washington, D.C. 20436 

Docket No. USTR-2018-0005 

Via submission 

RE: SOCMA Post-Hearing Rebuttal Comments on Proposed Determination of Action Pursuant to Section 301: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation 

Dear Sir or Madam: 

Per previously-submitted comments and testimony, the Society of Chemical Manufacturers & Affiliates (SOCMA) ask that the pharmaceuticals and chemicals used to make pharmaceuticals in the following tariff lines be removed from the Annex to the Federal Register notice: 

▪ HTS subheading 29146200 – 30063010 

Respectfully submitted, 

 Matthew Moedritzer 

Manager, Legal and Government Relations 

Society of Chemical Manufacturers & Affiliates (SOCMA) 

1400 Crystal Drive, Suite 630 

Arlington, VA 22202 

Categorized in: